<?xml version="1.0" encoding="UTF-8"?>
<p>Descriptive statistics were used throughout the study unless otherwise stated. For the primary efficacy endpoint and binary efficacy endpoints, point estimates and 80% confidence intervals (CI) were provided; all were based on investigator assessment data. Time‐to‐event endpoints were summarized using the Kaplan‐Meier method. Median event times and two‐sided 80% CIs were provided. Statistical analyses were performed using SAS version 9.4 (SAS Institute, Cary, NC).</p>
